戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 denoted treatment with none or 1 intravenous antiseizure drug.
2 noted treatment with more than 1 intravenous antiseizure drug.
3 ynchrony is modulated by epileptogenesis and antiseizure drugs.
4 sy contributes to seizures and resistance to antiseizure drugs.
5 st in 35% of patients despite optimal use of antiseizure drugs.
6 cant differences in plasma concentrations of antiseizure drugs.
7 s fail to become seizure-free in response to antiseizure drugs.
8 /ED50) that compared favorably with clinical antiseizure drugs.
9 ether epileptogenesis enhances synchrony and antiseizure drug administration disrupts it.
10  use of benzodiazepine drugs, phenobarbital, antiseizure drugs, and alpha-2 adrenergic drugs.
11 tives and antipsychotic, antidepressant, and antiseizure drugs as well as drugs of abuse, such as coc
12                                 The cause of antiseizure drug (ASD) resistance in epilepsy is poorly
13 Despite the availability of approximately 30 antiseizure drugs (ASDs), epilepsy remains a major unmet
14 seizures while minimizing adverse effects of antiseizure drugs (ASDs).
15 s indicated by the clinical finding that the antiseizure drug carbamazepine (CBZ) relieves pain becau
16 tchable derivatives of the widely prescribed antiseizure drug carbamazepine.
17 euronal excitability and highlight potential antiseizure drug development strategies based on the Na(
18          None of the patients was prescribed antiseizure drugs, either owing to physician recommendat
19 tients were categorized by administration of antiseizure drugs given during hospitalization.
20 eractions with targets reported for marketed antiseizure drugs, indicative of a novel and unprecedent
21 2A) is a presynaptic protein targeted by the antiseizure drug levetiracetam.
22 denoted treatment with 1 or more intravenous antiseizure drug, more than 1 intravenous anesthetic, an
23 etam; PET imaging tracer UCB-J; experimental antiseizure drug padsevonil; and allosteric modulator UC
24 acterized by seizures that respond poorly to antiseizure drugs, psychomotor delay, and cognitive and
25       Perampanel (PMP) is a third-generation antiseizure drug reported to be a potent and selective n
26                              The following 4 antiseizure drug strategies were included: (1) conservat
27                 Epilepsy therapy is based on antiseizure drugs that treat the symptom, seizures, rath
28 CANCE STATEMENT PMP is a regulatory approved antiseizure drug used for refractory partial-onset and g
29            In this study, the effects of the antiseizure drug valproic acid (VPA) on the expression o
30           Phenobarbital (PB), a broadly used antiseizure drug, was the first to be characterized as a
31                     Plasma concentrations of antiseizure drugs were quantified with the dose-normaliz
32 les include neuroinhibitory medications like antiseizure drugs, which are used against epilepsy and n
33  30% of focal epilepsies remain resistant to antiseizure drugs, with effective drug development imped